Dr. Kevin Tracey

So, yeah, it's been a long ride.

There is now the opportunity, I think, under Setpoint Medical's leadership with this new immunoregulator to turn the tables on what you said on the pharma industry dominance.

I mean, I'm sorry, Eric, if you and I were inventing anti-TNF tomorrow,

Oh, we go to the FDA and say, we got a drug that costs $100,000 a year.

It's going to have black box warning.

Some people are going to die from it.

Oh, and it's invasive.

It only works 40% of the time.

What do you think the FDA would say to us with those drugs today?

They would say, get out.

Yeah, yeah.

So there's an opportunity now for these devices to rewrite the book.

Eric, thank you for having me on.

Thank you for all you do to make the world more informed about science and medicine.

It makes it a better place.

We're grateful to you.